#Dana-Farber Cancer Institute

The approvals amount to a “game-changer for how we think about treating different groups of patients with AML.”

A genomic sequencing program revealed a genetic mutation that was able to be successfully treated with a checkpoint inhibitor.

The findings do not say that obesity causes cancer; other associated lifestyle factors may also contribute to increased risk.

“The more we continue to learn about different areas of the immune system, the more research and development of new drugs we’ll see.”

While her response is not average, doctors say it represents a step forward for people with diffuse midline gliomas, a rare cancer.

“The most important thing is to find someone you trust and are comfortable with to talk to.”

Dana-Farber’s Young-Onset Colorectal Cancer Center is one of the only centers dedicated to treating the diseases in people under age 50.

The trial is testing an experimental drug that targets one of the malignant immune cells that are a hallmark of the disease.

Their goal is to develop therapies to treat the disease

As treatment options evolve, so too does the push to better understand firefighters’ increased risk to certain cancers.

The entire brain processes music, giving it the power to influence mood and memory and making it a powerful therapeutic tool.

The issues and challenges associated with the disease are often quite different from those that arise in younger women.

Screening for precancerous conditions is a routine part of medical exams, especially as people age.

Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.

One participant in an ongoing clinical trial of a checkpoint inhibitor had her brain tumor completely disappear.

“The future of breast cancer therapy is tied to the idea of individualizing treatment for each patient,” says Sara Tolaney, MD, MPH.